Related Experiment Video
Updated: Nov 21, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Real-World Evidence and Glycemic Improvement Using Dexcom G6 Features
Halis Kaan Akturk1, Robert Dowd2, Kaushik Shankar2
1Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA.
Optional features of continuous glucose monitoring (CGM) systems benefit users. Increased use of alerts, data sharing, and analysis tools correlated with improved time in range (TIR) and better diabetes management.
Area of Science:
- Diabetes Technology
- Endocrinology
- Health Informatics
Background:
- Continuous glucose monitoring (CGM) systems offer optional features to enhance diabetes management.
- Understanding the utilization and impact of these features is crucial for optimizing patient care.
Purpose of the Study:
- To examine the associations between the use of optional CGM features, user demographics, and glycemic outcomes.
- To assess how different features are adopted and their impact on diabetes control.
Main Methods:
- Retrospective cohort study using data from US-based users of the G6 CGM System (Dexcom, Inc.).
- Analysis included sensor glucose values (SGVs) and utilization of alert features, remote data sharing (Share), retrospective pattern analysis (CLARITY), and a virtual assistant feature.
- Descriptive statistics were used to summarize feature adoption and correlate with glycemic outcomes like time in range (TIR).
Main Results:
- Most optional CGM features were widely adopted by users.
- Alert thresholds varied by age, with younger and older patients setting higher thresholds.
- Use of the Share feature was higher among younger patients and those with type 1 diabetes.
- Greater use of alert and notification features was associated with improved TIR.
- Engagement with CLARITY notifications and virtual assistant use correlated with higher TIR and lower mean SGV.
Conclusions:
- Optional features of the G6 CGM system are well-accepted and appear beneficial for patients.
- Demographics and personal circumstances influence how patients utilize CGM features for diabetes management.
- Personalized engagement with CGM features can lead to improved glycemic control.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Oral Hypoglycemic Agents: Glinides
Hypoglycemia and Glucagon
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Biguanides and Glitazones

